HUTCHMED (China) Limited
HMDCF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $2,737 | $3,246 | $2,541 | $4,051 |
| - Cash | $154 | $284 | $313 | $378 |
| + Debt | $90 | $86 | $27 | $39 |
| Enterprise Value | $2,673 | $3,048 | $2,255 | $3,712 |
| Revenue | $630 | $838 | $426 | $356 |
| % Growth | -24.8% | 96.5% | 19.7% | – |
| Gross Profit | $281 | $454 | $115 | $98 |
| % Margin | 44.6% | 54.1% | 27% | 27.5% |
| EBITDA | $14 | $67 | -$402 | -$207 |
| % Margin | 2.2% | 8% | -94.3% | -58.2% |
| Net Income | $38 | $101 | -$361 | -$195 |
| % Margin | 6% | 12% | -84.6% | -54.7% |
| EPS Diluted | 0.043 | 0.12 | -0.43 | -0.24 |
| % Growth | -64% | 127.9% | -79.2% | – |
| Operating Cash Flow | $0 | $219 | -$269 | -$204 |
| Capital Expenditures | -$18 | -$33 | -$37 | -$17 |
| Free Cash Flow | -$17 | $187 | -$305 | -$221 |